The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation
- 31 July 2004
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (7) , 904-913
- https://doi.org/10.4065/79.7.904
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyAnnals of Internal Medicine, 1999
- The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up studyThe American Journal of Medicine, 1995
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of internal medicine (1960), 1994
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989
- Atrial Fibrillation: A Major Contributor to Stroke in the ElderlyArchives of internal medicine (1960), 1987